North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2

Clinical trial NCT03548779 · COMPLETED

Trial details

NCT number: NCT03548779
Sponsor: University of North Carolina, Chapel Hill
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Epilepsy; Seizure Neuromuscular Diseases Brain Malformation Intellectual Disability Autism Spectrum Disorder Hypotonia Inborn Errors of Metabolism Movement Disorders Genetic Disease Development Delay Chromosome Abnormality Hearing Loss

Start date: 2018-09-28
Primary completion: 2023-09-08
Enrollment: 548

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.